CELLADON
Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. Celladon was founded in 2000 and is based in La Jolla, California.
CELLADON
Social Links:
Industry:
Biotechnology Health Care Hospital Therapeutics
Founded:
2000-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.celladon.net
Total Employee:
11+
Status:
Active
Contact:
(858) 366-4288
Email Addresses:
[email protected]
Total Funding:
152.55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cardiola
Cardiola is a biotechnology company developing therapeutic systems for the treatment of chronic heart failure.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Sabby Management
Sabby Management investment in Post-IPO Equity - Celladon
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Celladon
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Celladon
InterWest Partners
InterWest Partners investment in Post-IPO Equity - Celladon
Vivo Capital
Vivo Capital investment in Post-IPO Equity - Celladon
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Post-IPO Equity - Celladon
Life Sciences Partners
Life Sciences Partners investment in Venture Round - Celladon
MPM Capital
MPM Capital investment in Venture Round - Celladon
Pfizer Venture Investments
Pfizer Venture Investments investment in Venture Round - Celladon
GBS Ventures
GBS Ventures investment in Venture Round - Celladon
Official Site Inspections
http://www.celladon.net
- Host name: 172.67.166.78
- IP address: 172.67.166.78
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Celladon"
Celladon - Crunchbase Company Profile & Funding
Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include …See details»
Online Organization Welcomes All - Celladon - Stay …
These companies will certainly likewise help you market your organization by creating posts for your product or services. That can neglect the first of all online organizations, the online purchasing websites. A lot of real-world sellers have …See details»
Celladon – Stay Connected, Stay Inspired
The universe of data and correspondence innovation has increased its significance with the developing number of clients, becoming fundamental both for people and for the activity of organizations and organizations.See details»
About Us - Celladon - Stay Connected, Stay Inspired
The world of information and communication technology has multiplied its importance with the growing number of users, becoming essential both for individuals and for the operation of …See details»
Celladon Company Profile 2024: Valuation, Investors, Acquisition ...
Celladon General Information Description. Developer of molecular therapies designed for the treatment of cardiovascular diseases. The company's product candidate is designed to target …See details»
Celladon - VentureRadar
Biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases. Founded: 2000. ... Find out more about Celladon, Life Sciences, …See details»
Celladon - Contacts, Employees, Board Members, Advisors & Alumni
Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.See details»
Celladon - Crunchbase
Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.See details»
Celladon - The Lundbeck Foundation
Celladon Was in phase II/III trial with a SERCa2a gene therapy to help heart failure patients hearts to beat without increasing their oxygen consumption. Lundbeckfonden BioCapital. …See details»
Targeted Genetics’ Partner, Celladon Corporation, Reports …
Apr 28, 2010 Please refer to the press release issued by Celladon as seen at www.celladon.net for additional information regarding the development of MYDICAR and Celladon’s MYDICAR …See details»
Celladon - Company Presentation - YouTube
Oct 22, 2014 Presented by: Krisztina Zsebo, Ph.D., CEOCelladon is a clinical-stage biotechnology company developing novel therapies for diseases with tremendous unmet med...See details»
Celladon | VentureRadar
Biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases. Founded: 2000. ... Find out more about Celladon, Life Sciences, …See details»
Celladon pulls the plug on R&D after a crushing gene therapy failure
Jun 26, 2015 Celladon's shares have fallen nearly 90% since the biotech disclosed Mydicar's data, trading at around $1.50. Earlier this month, CEO Krisztina Zsebo resigned after a decade …See details»
Gene Therapy for Heart Failure: Back to the Bench - PMC
Oct 7, 2015 Gene therapy for heart failure hit another bump on the road to clinical translation with the announcement by Celladon that its lead product Mydicar—adeno-associated viral …See details»
Celladon | Biotechnology - The Pharmaletter
In February 2014 it was announced that Celladon had entered into an option agreement with French independent drugmaker Laboratories Servier for a potential worldwide ex-US research …See details»
Marketing Agency - Celladon - Stay Connected, Stay Inspired
I am composing this on the assumption that the job of discovering the ideal marketing agency for your company lags you and that you are now in the optimal setting to start leveraging that …See details»
Phase 2 study of Mydicar for the treatment of advanced heart failure
Apr 28, 2010 For more information call (858) 366-4288 or visit www.celladon.net. Picked For You Atogepant Efficacious for Patients With Chronic MigraineSee details»
Celladon Merger: A Win/Win/Win For All: Evaluating Existing ...
Celladon estimates that if a merger, sale or liquidation transaction were to be completed in the second half of 2015, its net cash immediately prior to the transaction and/or available for ...See details»
Is this the end of the line for Celladon after its gene therapy flop?
Jun 29, 2015 Celladon specializes in gene therapy. But its key therapy, Mydicar, failed in a mid-stage trials earlier this year, and now the firm is saying it may be forced to liquidate if it cannot …See details»
Digital Marketing Services - Celladon - Stay Connected, Stay Inspired
Every organization is struggling to stay on top of immediately evolving consumer actions. A tailored marketing technique can help an organization to know what consumers yearn for. …See details»